Pliant Therapeutics

Directions Website Contact the business

Pliant Therapeutics Pliant Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics.

Thrilled to welcome Craig to the Pliant leadership team. A recognized leader in RNAi drug discovery, Craig brings an ext...
10/20/2026

Thrilled to welcome Craig to the Pliant leadership team. A recognized leader in RNAi drug discovery, Craig brings an extensive track record of over two decades of advancing novel delivery platforms and therapeutics, alongside a deep proficiency in RNAi and oligonucleotide chemistry and delivery. Learn more about Craig: https://lnkd.in/g_xSVi33

We’re pleased to announce that the U.S. FDA has granted Fast Track designation to PLN-101095, our oral, small molecule, ...
08/18/2026

We’re pleased to announce that the U.S. FDA has granted Fast Track designation to PLN-101095, our oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins, in combination with pembrolizumab for the treatment of solid tumors that are resistant to immune checkpoint inhibitors. This designation is supported by encouraging Phase 1a data demonstrating anti-tumor activity and a favorable safety profile for this combination in immune checkpoint inhibitor resistant solid tumors.

We look forward to continuing to work closely with the FDA to accelerate the development of PLN-101095.

Read the press release here: https://lnkd.in/gCkg_qw2

Excited to present FORTIFY, our ongoing Phase 1b trial, to the global oncology community at the 2026 American Society of...
05/21/2026

Excited to present FORTIFY, our ongoing Phase 1b trial, to the global oncology community at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. FORTIFY is an indication expansion trial investigating PLN-101095 in combination with pembrolizumab that is enrolling patients with certain immune checkpoint inhibitor (ICI)-refractory advanced or metastatic solid tumors. Presentation details: https://lnkd.in/gm2jwWqF

Address

331 Oyster Point Boulevard
South San Francisco, CA
94080

Alerts

Be the first to know and let us send you an email when Pliant Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pliant Therapeutics:

Shortcuts

Share

Nearby businesses